Our vision/ antimicrobial stewardship

The task force will focus mainly on Antimicrobial Stewardship in Human beings .

What is ANTIMICROBIAL STEWARDSHIP and how does it differ from Antimicrobial Resistance?

Antimicrobial resistance (AMR) is a growing global health crisis that occurs when microbes, such as bacteria, viruses, fungi, and parasites, develop the ability to resist the effects of antimicrobial drugs, which are medicines used to treat infections. This resistance makes it difficult or impossible to treat infections caused by these microbes, leading to more serious illnesses, longer hospital stays, and increased mortality rates.

How Antimicrobial Resistance Happens

Antimicrobial resistance is a natural process that occurs through genetic changes in microbes. These changes can occur randomly or be acquired through horizontal gene transfer, where genetic material is exchanged between microbes. When a microbe develops resistance to an antimicrobial drug, it can pass this resistance on to other microbes, making the problem even more widespread.

The Dangers of Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to global health, as it can make common infections difficult or impossible to treat. This can lead to a number of serious consequences, including:

  • Increased mortality rates: Resistant infections can be more difficult to treat, leading to higher rates of death and disability.

  • Longer hospital stays: Patients with resistant infections often require longer hospital stays, which can lead to increased healthcare costs and a greater risk of complications.

  • Spread of resistant infections: Resistant microbes can spread easily between people, making it difficult to control outbreaks of infection.

Factors Contributing to Antimicrobial Resistance

Several factors contribute to the development and spread of antimicrobial resistance, including:

  • Overuse and misuse of antimicrobials: The overuse and misuse of antimicrobials in humans, animals, and agriculture are major drivers of antimicrobial resistance. When antimicrobials are used unnecessarily or incorrectly, they can create an environment where resistant microbes are more likely to thrive.

  • Lack of access to clean water and sanitation: Poor sanitation and hygiene practices can contribute to the spread of infectious diseases, which can lead to increased use of antimicrobials and the development of resistance.

  • Lack of investment in research and development of new antimicrobials: The development of new antimicrobial drugs is expensive and time-consuming. As a result, there is a lack of investment in research and development, which makes it difficult to keep up with the emergence of new resistant microbes.

Preventing and Combating Antimicrobial Resistance

Several strategies can be used to prevent and combat antimicrobial resistance, including:

  • Promoting the responsible use of antimicrobials: It is important to use antimicrobials only when they are truly needed and to follow the prescribed dosage and duration of treatment.

  • Improving sanitation and hygiene: Good sanitation and hygiene practices can help to prevent the spread of infectious diseases and reduce the need for antimicrobials.

  • Investing in research and development of new antimicrobials: Increased investment in research and development is needed to develop new antimicrobial drugs and other tools to combat antimicrobial resistance.

  • Strengthening surveillance and monitoring systems: Effective surveillance and monitoring systems can help to track the spread of antimicrobial resistance and identify outbreaks early.

  • Promoting infection prevention and control practices: Strict infection prevention and control practices can help to reduce the spread of infections in healthcare settings.

Antimicrobial resistance is a serious global health threat that requires a coordinated effort to address. By taking steps to prevent and combat antimicrobial resistance, we can help to protect public health and ensure that future generations have access to effective antimicrobial treatments.

What is ANTIMICROBIAL STEWARDSHIP and how does it differ from Antimicrobial Resistance?

In the fight against antimicrobial resistance, there are multiple avenues where interventions can be applied. NNAST  will support the government and other agencies who are working to reduce the indiscriminate use of antibiotics.  We plan to scale up antimicrobial stewardship, surveillance, and research  in the field.

Antimicrobial stewardship is a program that aims to reduce the misuse and overuse of antibiotics  and other antimicrobial medications to prevent microbial resistance.  These medications are essential for treating infections, but their misuse has led to antibiotic resistance, which occurs when bacteria and fungi develop the ability to resist the drugs that are meant to kill them.

Antimicrobial stewardship programs (ASPs) use a variety of strategies and techniques to optimize the use of antibiotics in hospitals. These programs aim to ensure that patients receive the correct antimicrobial for the right infection , no antimicrobial if there is no infection , at the right time, the right dose, and appropriate minimal duration for their diagnosis.

The task force’s activities in this field will include:

  • Working with healthcare facilities to establish and strengthen their antimicrobial stewardship programs

Improving identification of resistant organisms

Coordinating research and surveillance activities on antimicrobial resistance (AMR)

  • Creating an AMR data platform

  • Promoting education and enlightenment on AMR  in both  health care personnel and the general public

Capacity building for the Nigerian  healthcare systems on AMS.

Scroll to Top

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.